AlphaYouPB
Insider selling
Peter Blume-Jensen sold $31K of Acrivon Therapeutics, Inc. (ACRV) stock
Peter Blume-Jensen, President and CEO of Acrivon Therapeutics, Inc. (ACRV), sold 14,036 shares of ACRV stock worth $31K, per an SEC Form 4 filed Aug 27, 2026.
It was an open-market sale.
The trade happened on Aug 25, 2026, 2 days before it was made public.
ACRV has moved -1.4% since the trade date, from $2.18 to $2.15 (Sep 22, 2026 close).
- Traded
- Aug 25, 2026
- Disclosed
- Aug 27, 2026
- Filing delay
- 2 days
- Price since
- -1.4%
- Role
- President and CEO
- Source
- SEC Form 4
More ACRV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.